Dr. Henry S. Park
Claim this profileYale University
Studies Cancer
Studies Small Cell Lung Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage III
2Small Cell Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Henry S. Park is currently running
BgRT + SBRT + Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy (SBRT) with osimertinib works for the treatment of EGFR positive non-small cell lung carcinoma that has spread from where it first started (primary site) to a limited number of anatomic sites (oligoprogressive). BgRT is radiation that uses specialized imaging to during treatment to target the active tumor and direct radiation to tumors in order to kill and shrink tumor cells. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Osimertinib is in a class of medications called kinase inhibitors. It works by blocking the action of a protein called EGFR that signals cancer cells to multiply. This helps slow or stop the spread of tumor cells. Giving BgRT with SBRT and osimertinib may kill more tumor cells in patients with oligoprogressive EGFR positive non-small cell lung carcinoma.
Recruiting1 award Phase 214 criteria
Radiation Therapy + Atezolizumab
for Small Cell Lung Cancer
This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radiation therapy in addition to atezolizumab may extend the time without extensive small cell lung cancer growing or spreading compared to atezolizumab alone.
Recruiting1 award Phase 2 & 311 criteria
More about Henry S. Park
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Henry S. Park has experience with
- Atezolizumab
- Cisplatin
- Fluorouracil
- Gemcitabine Hydrochloride
- Paclitaxel
- Intensity-Modulated Radiation Therapy
Breakdown of trials Henry S. Park has run
Cancer
Small Cell Lung Cancer
Lung Cancer
Small Cell Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Henry S. Park specialize in?
Henry S. Park focuses on Cancer and Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Henry S. Park currently recruiting for clinical trials?
Yes, Henry S. Park is currently recruiting for 3 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Henry S. Park has studied deeply?
Yes, Henry S. Park has studied treatments such as Atezolizumab, Cisplatin, Fluorouracil.
What is the best way to schedule an appointment with Henry S. Park?
Apply for one of the trials that Henry S. Park is conducting.
What is the office address of Henry S. Park?
The office of Henry S. Park is located at: Yale University, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.